U.S. flag

An official website of the United States government

NM_001999.4(FBN2):c.3584G>A (p.Arg1195His) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 8, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000522133.1

Allele description [Variation Report for NM_001999.4(FBN2):c.3584G>A (p.Arg1195His)]

NM_001999.4(FBN2):c.3584G>A (p.Arg1195His)

Gene:
FBN2:fibrillin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q23.3
Genomic location:
Preferred name:
NM_001999.4(FBN2):c.3584G>A (p.Arg1195His)
HGVS:
  • NC_000005.10:g.128338011C>T
  • NG_008750.1:g.205033G>A
  • NM_001999.4:c.3584G>AMANE SELECT
  • NP_001990.2:p.Arg1195His
  • NC_000005.9:g.127673703C>T
  • NM_001999.3:c.3584G>A
Protein change:
R1195H
Links:
dbSNP: rs751600209
NCBI 1000 Genomes Browser:
rs751600209
Molecular consequence:
  • NM_001999.4:c.3584G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000617878GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Aug 8, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000617878.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The R1195H variant of uncertain significance in the FBN2 gene has not been published as pathogenic or been reported as benign to our knowledge. R1195H is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R1195H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals, however, H1195 is the wild-type residue in at least one species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Finally, although located within a calcium-binding EGF-like domain of the FBN2 gene, the R1195H variant does not affect a Cysteine residue. Cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with congenital contractural arachnodactyly (Frédéric et al., 2009).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024